10月31日 - ** 生物技术公司银杏生物DNA.N股价盘前上涨3.3%至12.41美元
** 该公司称拜耳延长了与银杏的多年合作关系，以开发新的农业生物产品
** DNA表示，双方的合作始于2017年，重点是开发微生物解决方案，帮助作物吸收氮，减少对合成肥料的依赖
** 该公司表示，拜耳将保留合作所产生的任何产品的商业化权利
** 总部位于波士顿的 DNA 公司开发各种工具，使从农业到医疗保健等行业的生物解决方案工程化变得更容易。
** 截至上一交易日收盘，股价年累计上涨约 22
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.